Fetal hemoglobin in sickle cell disease: Relationship to erythrocyte phosphatidylserine exposure and coagulation activation

Blood

Volumn 96, Issue 3, 2000, Pages 1119-1124

  Setty, B N Y ^a   Kulkarni, S ^a   Rao, A K ^a   Stuart, M J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCKING PROTEIN; HEMOGLOBIN F; HEMOGLOBIN S; PHOSPHATIDYLSERINE; PROTHROMBIN; THROMBIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD CLOTTING; CELL VACUOLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; INFANT; NEWBORN; PRIORITY JOURNAL; PROTHROMBIN TIME; SICKLE CELL ANEMIA; THROMBIN TIME;

EID: 0034254238     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.3.1119     Document Type: Article

References (42)

1. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells: A review
2. Erythrocyte membrane lipid reorganization during the sickling process
3. Uncoupling of the membrane skeleton from the lipid bilayer: The cause of accelerated phospholipid flipflop leading to an enhanced procoagulant activity of sickled cells
4. Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells: Mechanism and physiologic significance
5. Measurement of membrane phospholipid asymmetry in normal and sickle erythrocytes by means of annexin V binding
6. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V
7. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: Flow-cytometric measurement and clinical associations
8. Phosphatidylserine in the outer leaflet of red blood cells from β- thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes
9. Membrane phospholipid asymmetry in human thalassemia
10. Transbilayer movement of phospholipids in red cell and platelet membranes
11. ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: Relation to shape changes
12. Maintenance and consequences of membrane phospholipid asymmetry
13. Measurement of outward translocation of phospholipids across human erythrocyte membrane
14. Bidirectional transbilayer movement of phospholipid analogs in human red blood cells
15. Role of translocases in the generation of phosphatidyl-serine asymmetry
16. Mechanism and function of changes in membrane phospholipid asymmetry in platelets and erythrocytes
17. Phosphatidylserine externalization in subpopulations of sickle cells
18. Transmembrane mobility of phospholipids in sickle erythrocytes: Effect of deoxygenation on diffusion and asymmetry
19. Red cell membrane remodeling in sickle cell anemia: Sequestration of membrane lipids and proteins in Heinz bodies
20. Oxidative damage does not alter membrane phospholipid asymmetry in human erythrocytes
21. Cation homeostasis
22. Structural bases of the inhibitory effects of hemoglobin F. and hemoglobin A2 on the polymerization of hemoglobin S
23. Immunochemical estimation of haemoglobin types in red blood cells by FACS analysis
24. Detection of hemoglobin variants in erythrocytes by flow cytometry
25. Epitope mapping of annexin I: Antibodies that compete with phospholipids and calcium recognize amino acids 42-99
26. Annexins: The problems of assessing the biological role for a gene family of multifunctional calcium and phospholipid binding proteins
27. Fetal hemoglobin in sickle cell anemia: Determinants of response to hydroxyurea
28. Variation in fetal hemoglobin parametere and predicted HbS polymerization in sickle cell children in the first two years of life: Parisian prospective study on sickle cell disease
29. Fetal hemoglobin, sickling and sickle cell disease
30. Mortality in sickle cell disease: Life expectancy and risk factors for early death
31. Pain in sickle cell disease: Rates and risk factors
32. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
33. Hemostasis in sickle cell disease
34. Is sickle cell crisis a thrombotic event?
35. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease
36. Tissue factor expression by endothelial cells in sickle cell anemia
37. Adherence of phosphatidylserine exposing erythrocytes to endothelial cell monolayers
38. In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes
39. Functional asplenia in sickle cell anemia
40. Plasma factor VII and thrombin-anti-thrombin III levels indicate increased tissue factor activity in sickle cell patients
41. Prothrombotic changes in children with sickle cell disease: Relationships to cerebrovascular disease and transfusion
42. Increased RBC phosphatidylserine exposure in sickle cell disease patients at risk for stroke by transcranial Doppler screening